← FDA Drug Approvals (Drugs@FDA)

OHTUVAYRE

NDA · New Drug Application · Sponsor: MSD · Approved 2024-06-26

Drug application

FDA Application #

NDA217389

Application type

New Drug Application

Brand name

OHTUVAYRE

Generic name

ENSIFENTRINE

Active ingredients

ENSIFENTRINE

Dosage form

SUSPENSION

Route

INHALATION

Marketing status

Prescription

Sponsor

MSD

Manufacturer

MERCK SHARP & DOHME LLC

First approval

2024-06-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown